Autonomic Testing in Subclinical Carotid Atherosclerosis
AtheroDetect
Early Detection of Subclinical Carotid Atherosclerosis Through Autonomic Testing
1 other identifier
observational
101
0 countries
N/A
Brief Summary
Background: Atherosclerotic carotid intima-media thickness (IMT) may be associated with alterations in the sensitivity of carotid and subclavian baroreceptors. Aim: The aim of this study is to investigate if carotid IMT is associated with changes in the autonomic modulation of the heart rate variability (HRV). Methods: This is a prospective cross-sectional study. The carotid IMT is determined by B-mode and duplex ultrasonography. The cardiovagal function was determined through linear and nonlinear measures of HRV. Linear regression models, adjusted for demographics, comorbidities, body mass index, waist-hip-ratio, and left ventricular ejection fraction will be used to evaluate the association between HRV parameters and carotid IMT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 29, 2016
CompletedFirst Posted
Study publicly available on registry
April 1, 2016
CompletedJanuary 24, 2018
March 1, 2016
1.3 years
March 29, 2016
January 23, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
carotid intima-media thickness (IMT)
carotid IMT is determined by B-mode and duplex ultrasonography
1 day
cardiovagal function
the cardiovagal function is determined through linear and nonlinear measures of HRV
1 day
Eligibility Criteria
Subjects referred to the Heart Institute of Santa Casa Charity (IACOR), Fernandopolis, Brazil for noninvasive carotid artery duplex ultrasonography. Carotid arteriosclerotic disease is evaluated through measuring the IMT and calculating the plaque score.
You may qualify if:
- Asymptomatic patients aged 18 years and older without a history of transient ischemic attack, stroke, or other neurologic signs or symptoms are selected to participate in the study.
You may not qualify if:
- Patients with symptomatic carotid artery stenosis were excluded if the patient had transient or permanent focal neurologic symptoms related to the ipsilateral retina or the cerebral hemisphere.
- Patients with heart rhythm disorders, pacemaker, heart failure, ejection fraction less than 0.45, chronic renal failure on hemodialysis, severe liver failure, myocardial infarction, endarterectomy, carotid angioplasty, carotid dissection and carotid occlusion were excluded.
- Patients receiving drugs known to interfere with autonomic function, such as beta-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, vasodilators, statins, neuroleptics and nasal vasoconstrictors, were discontinued for 24 hours before the tests.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY CHAIR
Ovidiu C Baltatu, MD PhD
Universidade Camilo Castelo Branco
- STUDY DIRECTOR
Valter L Pereira Jr., MD
Heart Institute of Santa Casa Charity (IACOR) Fernandopolis
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 29, 2016
First Posted
April 1, 2016
Study Start
September 1, 2014
Primary Completion
January 1, 2016
Study Completion
March 1, 2016
Last Updated
January 24, 2018
Record last verified: 2016-03
Data Sharing
- IPD Sharing
- Will not share